Latest News & Blogs

GSK & Associates

How will the increase in the Service Tax (SST) rate from 6% to 8% impact businesses and consumers?

We wish to draw your attention to the recent revision in the Service Tax rate, which has been increased from 6% to 8%, effective from 1...

GSK & Associates

Waiver of debts - taxable or not?

Waiver of debts - taxable or not?. While it may seem like a tremendous relief, the IRB might still consider it as taxable income.

GSK & Associates

Budget 2023 - Corporate and Individual tax in Malaysia

Explore the Impact of Malaysia's Budget 2023 Key Tax Changes on Corporate and Individual Tax in Malaysia.

GSK & Associates

Special Voluntary Disclosure Programme 2.0 in Malaysia

SVDP 2.0 targets taxpayers who have either not paid or underpaid their taxes to voluntarily report their income.

GSK & Associates

e-Invoice Malaysia

e-Invoice is the exchange of information in an invoice between a supplier and a buyer in a controlled electronic mechanism.

GSK & Associates

Key differences between MPERS, IFRS for SMEs and MFRS

An overview of the key differences between MPERS, IFRS for SMEs and MFRS in Malaysia.

GSK & Associates

Individual income tax in Malaysia

Individual income tax in Malaysia with details of tax due dates, residence status, reliefs and rebates for the year of assessment 2022.

GSK & Associates

Reduced rates for tax penalties

Effective 1 May 2022, tax penalties imposed under Section 113 (2) of the Income Tax Act, 1967 (ITA) are at a new, reduced graduated scale.

GSK & Associates

Redeemable Preference Shares (RPS) - Liability or Equity

Classification of Redeemable Preference Shares (RPS) as Liability or Equity as prescribed by IAS 32 or MFRS 132.